Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart H Cohen

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
Treatments for hepatitis BDavid M Asmuth, Hien H Nguyen, Gregory P Melcher, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2008
Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infectionHsin Huang, Stuart H Cohen, Jeff H King, et al.
Journal of Clinical Microbiology|July 11, 2006
Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, CaliforniaHsin Huang, Neil M Flynn, Jeff H King, et al.
Practical Laboratory Medicine|July 12, 2022
Comparative performance of COVID-19 serology testingNam K Tran, Larissa May, Stuart H Cohen, et al.
Infection Control and Hospital Epidemiology|February 24, 2025
Risk factors for the development of <i>Clostridioides difficile</i> infection in patients colonized with toxigenic <i>Clostridioides difficile</i>Josh Clement, Gauri Barlingay, Sindhu Addepalli, et al.
Diagnostic Microbiology and Infectious Disease|May 3, 2006
Prevalence of enterotoxigenic Bacteroides fragilis in hospital-acquired diarrheaStuart H Cohen, Razeq Shetab, Yajarayma J Tang-Feldman, et al.
Journal of Clinical Microbiology|June 14, 2012
Serum (1->3)-β-D-glucan measurement in coccidioidomycosisGeorge R Thompson, Derek J Bays, Suzanne M Johnson, et al.
American Journal of Infection Control|December 3, 2016
Antimicrobial stewardship programs that target only high-cost, broad-spectrum antimicrobials miss opportunities to reduce Clostridium difficile infectionsChristine Bui, Elizabeth Zhu, Monica A Donnelley, et al.
Journal of Clinical Microbiology|October 12, 2012
Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi testsClare E Gyorke, Susan Wang, Jhansi L Leslie, et al.
Diagnostic Microbiology and Infectious Disease|September 27, 2012
Outcomes in patients tested for Clostridium difficile toxinsChristopher R Polage, David L Chin, Jhansi L Leslie, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
Treatments for hepatitis BDavid M Asmuth, Hien H Nguyen, Gregory P Melcher, et al.
Diagnostic Microbiology and Infectious Disease|January 8, 2008
Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infectionHsin Huang, Stuart H Cohen, Jeff H King, et al.
Journal of Clinical Microbiology|July 11, 2006
Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, CaliforniaHsin Huang, Neil M Flynn, Jeff H King, et al.
Practical Laboratory Medicine|July 12, 2022
Comparative performance of COVID-19 serology testingNam K Tran, Larissa May, Stuart H Cohen, et al.
Infection Control and Hospital Epidemiology|February 24, 2025
Risk factors for the development of <i>Clostridioides difficile</i> infection in patients colonized with toxigenic <i>Clostridioides difficile</i>Josh Clement, Gauri Barlingay, Sindhu Addepalli, et al.
Diagnostic Microbiology and Infectious Disease|May 3, 2006
Prevalence of enterotoxigenic Bacteroides fragilis in hospital-acquired diarrheaStuart H Cohen, Razeq Shetab, Yajarayma J Tang-Feldman, et al.
Journal of Clinical Microbiology|June 14, 2012
Serum (1->3)-β-D-glucan measurement in coccidioidomycosisGeorge R Thompson, Derek J Bays, Suzanne M Johnson, et al.
American Journal of Infection Control|December 3, 2016
Antimicrobial stewardship programs that target only high-cost, broad-spectrum antimicrobials miss opportunities to reduce Clostridium difficile infectionsChristine Bui, Elizabeth Zhu, Monica A Donnelley, et al.
Journal of Clinical Microbiology|October 12, 2012
Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi testsClare E Gyorke, Susan Wang, Jhansi L Leslie, et al.
Diagnostic Microbiology and Infectious Disease|September 27, 2012
Outcomes in patients tested for Clostridium difficile toxinsChristopher R Polage, David L Chin, Jhansi L Leslie, et al.
Pageof 8